Galena Biopharma fka GALE

[Euripides90]

MotleyF bloggers have been singing that refrain for a long time but by documented accounts company has bought time cash-flow-wise til at least 2017 even if nothing changes, with the public offering, which hurt the price tho. Some bloggers admit to being short on the stock.

All biotechs except the biggies have heavy R&D expenses, if they want to do the research and testing right -- otherwise they risk failure.
Cash is always tight for every biotech, always a gamble but they fight the good fight and the upside is huge -- this one IMO solid.

We saw it hit $2.25 again recently B4 declining again to near lows, it's also been documented that is one of the biotechs most beset by shorting sharks. Current PPS plunge has lowered one-year target to somewhere around $3.50 which is disappointing but that is very fluid, changes with current price trends in a flash.

IMO rumors of being a buy-out candidate are case of where there's so much smoke there's some fire, sure hope s/thing hits BIG soon!

Earnings growth for 2015 is almost 4X industry average!
And YET price still plunges and plunges on voiced skepticism:
real or calculated to move price down?

http://www.nasdaq.com/symbol/gale/analyst-research